B
신일제약
012790KOSDAQ의약품 제조업55.5 / 100
Reference Date: 2026-06-10
Financial Score28.0 / 40
News Sentiment12.5 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Declined 14.7% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Shinil Pharmaceutical, established in 1971, specializes in the production and sale of various pharmaceuticals such as tablets, capsules, and ointments, while also operating a CDMO business. The company diversifies its operations through the 'Pamtree' brand, offering functional cosmetics and health supplements, alongside revenue from medical devices and real estate rentals.
Number of Employees
413people
Average Salary
49.9M KRW
Score Calculation Basis
Detailed Financial Score
PER
7.93Industry Average 11.936.5Point
Lower than industry avg (good)
PBR
0.41Industry Average 0.897.0Point
Half of industry avg (excellent)
ROE
5.04Industry Average 4.014.0Point
In line with industry avg
Debt Ratio
1.62Industry Average 12.438.0Point
Half of industry avg (excellent)
Trend 2023~20252.5 / 10 points
Revenue Growth Rate
0.5 / 3
Avg ▼4.8% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼21.3% (2-year basis)
ROE Trend
2.0 / 4
Avg ROE 8.6% (declining, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (0%, downtrend)
Current 5,160Won52-week high 6,92052-week low 5,160
1-month return1.0Point
1m -14.71% (falling)
Volume trend3.0Point
Volume flat
Detailed Disclosure
2 totalPositive 0Neutral 2Negative 0
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-04
- Neutral분기보고서 (2026.03)2026-05-15